|
May. 20, 2015 |
|
|
Dec. 17, 2018 |
|
|
jRCT2080222857 |
The long term administration study of MRQ-01 in the cancer patients with breakthrough pain |
|
| version: date: |
MARUISHI PHARMACEUTICAL CO.,LTD |
||
81-6-6962-0318 |
||
| 50 | ||
Interventional |
||
Multicenter : open-label, uncontrolled |
||
3 |
||
The cancer-related breakthrough pain which rescue needs |
||
| 20age old over | ||
| No limit | ||
Both |
||
Cancer-related breakthrough pain |
||
investigational material(s) |
||
| Maruishi Pharmaceutical Co., Ltd. | |
| JapicCTI-152909 | |